Cover Image
市場調查報告書

正子斷層掃描 (PET) 設備的全球市場:醫療設備的開發平台評估

Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2018

出版商 GlobalData 商品編碼 358892
出版日期 內容資訊 英文 72 Pages
訂單完成後即時交付
價格
Back to Top
正子斷層掃描 (PET) 設備的全球市場:醫療設備的開發平台評估 Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2018
出版日期: 2018年04月13日 內容資訊: 英文 72 Pages
簡介

本報告提供全球正子斷層掃描 (以下簡稱PET) 系統市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再加上產品的功能·特性比較分析 (臨床實驗的各進展階段) ,再彙整主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 正子斷層掃描 (PET) 系統概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • PET設備的企業:各臨床實驗階段的開發中產品
  • PET設備:各臨床實驗階段的開發中產品

第5章 PET設備市場:企業·產品概要

  • Brain Biosciences Inc
    • 開發中產品及進行中的臨床實驗概要
  • GE Healthcare Limited
  • Jagiellonian University
  • Philips Healthcare
  • Ray Vision Intl Corp.
  • Stanford University
  • SynchroPET
  • The University of British Columbia
  • Zecotek Photonics Inc.

第6章 PET設備市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0535EPD

GlobalData's Medical Devices sector report, "Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2018" provides an overview of Positron Emission Tomography (PET) Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Positron Emission Tomography (PET) Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Positron Emission Tomography (PET) Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Positron Emission Tomography (PET) Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Positron Emission Tomography (PET) Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Positron Emission Tomography (PET) Systems Overview 6

3 Products under Development 7

  • 3.1 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 7
  • 3.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Territory 8
  • 3.3 Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path 9
  • 3.4 Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date 10

4 Positron Emission Tomography (PET) Systems - Pipeline Products under Development by Companies 11

  • 4.1 Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development 11
  • 4.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 12

5 Positron Emission Tomography (PET) Systems Companies and Product Overview 13

  • 5.1 Brain Biosciences Inc Company Overview 13
    • 5.1.1 Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 13
  • 5.2 GE Healthcare LLC Company Overview 15
    • 5.2.1 GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.3 General De Equipment for Medical Imaging SA Company Overview 16
    • 5.3.1 General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.4 Jagiellonian University Company Overview 17
    • 5.4.1 Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.5 Lightpoint Medical Ltd Company Overview 18
    • 5.5.1 Lightpoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.6 Philips Healthcare Company Overview 19
    • 5.6.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.7 Ray Vision Intl Corp. Company Overview 20
    • 5.7.1 Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.8 Stanford University Company Overview 21
    • 5.8.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.9 SynchroPET Company Overview 26
    • 5.9.1 SynchroPET Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.10 University of British Columbia Company Overview 28
    • 5.10.1 University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.11 University of California Davis Company Overview 29
    • 5.11.1 University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.12 University of Washington Company Overview 30
    • 5.12.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.13 West Virginia University Company Overview 33
    • 5.13.1 West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 33

6 Positron Emission Tomography (PET) Systems- Recent Developments 34

  • 6.1 Mar 12, 2018: Zecotek Introduces Innovative Wireless ASIC Microchip For Positron Emission Tomography Medical Imaging 34
  • 6.2 Mar 06, 2018: Agfa HealthCare and Hitachi Healthcare Americas Will Cover Full Imaging Portfolio at AAOS 2018 Booth 34
  • 6.3 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017 35
  • 6.4 Feb 13, 2018: SNMMI and ASNC Issue Joint Guidelines for Quantification of Myocardial Blood Flow Using PET 36
  • 6.5 Feb 06, 2018: AC Immune to Participate in Two Investor Conferences and Provide Scientific Updates at AAT-AD/PD Conference 36
  • 6.6 Jan 30, 2018: Siemens Healthineers Names Deepak Nath Head of Laboratory Diagnostics 38
  • 6.7 Jan 16, 2018: Oncovision, Enhancing Precision Medicine at RSNA'17 38
  • 6.8 Jan 16, 2018: Siemens Healthineers lays out strategy to bolster market leadership beyond 2025 39
  • 6.9 Jan 11, 2018: Andover will lose nearly 2,000 jobs with Philips move 41
  • 6.10 Jan 03, 2018: Total-Body PET: Maximizing Sensitivity for Clinical Research and Patient Care 41
  • 6.11 Dec 11, 2017: Presurgical imaging may predict whether epilepsy surgery will work 43
  • 6.12 Dec 08, 2017: Molecular beacon signals low oxygen with ultrasound 44
  • 6.13 Dec 06, 2017: PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment 45
  • 6.14 Nov 30, 2017: In the Samara Region, the First Regional Nuclear Medical Center Has Opened 46
  • 6.15 Nov 29, 2017: Siemens plans to list Siemens Healthineers on Frankfurt Stock Exchange 47
  • 6.16 Nov 17, 2017: Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017 47
  • 6.17 Nov 07, 2017: Diagnosing Alzheimer's With Diamonds and PET Scans 48
  • 6.18 Oct 30, 2017: European OEM Adopts Zecotek's LFS Scintillation Crystal for Line of Positron Emission Tomography Medical Scanning Devices 49
  • 6.19 Oct 24, 2017: Michael J. Fox Foundation and Tau Consortium Announce Partnership to Develop New Imaging Tools for Devastating Neurodegenerative Diseases 50
  • 6.20 Sep 25, 2017: IXICO to provide specialist MR and PET imaging services in Phase II Huntington's disease clinical trial 51
  • 6.21 Sep 19, 2017: PET imaging tracks Zika virus infection, disease progression in mouse model 51
  • 6.22 Sep 11, 2017: An opportunity to evaluate and speed-up new projects - Meet GE Healthcare at the Uppsala BIO booth 52
  • 6.23 Aug 22, 2017: Clinical Study Shows that Retinal Imaging may Detect Signs of Alzheimer's Disease 53
  • 6.24 Aug 16, 2017: LFS Scintillation Crystals for Neuropet Brain Scanning Device 54
  • 6.25 Aug 10, 2017: New measure of insulin-making cells could gauge diabetes progression, treatment 55
  • 6.26 Aug 10, 2017: Dynasil's RMD Subsidiary Awarded $2.1 Million in Technology Development Grants by the National Institute of Health and NASA 56
  • 6.27 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 57
  • 6.28 Jul 24, 2017: USF Health Byrd Alzheimer's Institute finds amyloid PET scan leading to better Alzheimer's disease management 58
  • 6.29 Jul 17, 2017: Zecotek China Appoints Business Development Director 58
  • 6.30 Jul 06, 2017: Novel PET Tracer Detects Small Blood Clots 59
  • 6.31 Jul 04, 2017: Zecotek Receives $1.2 Million purchase orders for Patented LFS Scintillation Crystals 60
  • 6.32 Jun 30, 2017: Zecotek China Working with PET OEMs and Gaining Access to Industries Beyond Medical Scanning 60
  • 6.33 Jun 24, 2017: European Hematology Association: Early Metabolic Response Determination by FDG-PET Allows Substantial Reduction of Chemotherapy and its Toxicity in Patients with Advanced Stage Hodgkin Lymphoma 61
  • 6.34 Jun 14, 2017: PET imaging to predict tumor response 62
  • 6.35 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 62
  • 6.36 May 31, 2017: Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017 63
  • 6.37 May 30, 2017: Zecotek Receives $100,000 Order for Patented LFS Scintillation Crystals from Major Chinese OEM 64
  • 6.38 May 25, 2017: Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors 65
  • 6.39 May 24, 2017: Zecotek Delivers Patented LFS Scintillation Crystals to Multiple High Tech Institutions 65
  • 6.40 May 16, 2017: Zecotek Provides Update to Exclusive Distribution Agreement With EBO Optoelectronics and Establishes Subsidiary in China 66
  • 6.41 May 15, 2017: Threshold Pharmaceuticals Reports First Quarter Financial Results 67

7 Appendix 69

  • 7.1 Methodology 69
  • 7.2 About GlobalData 72
  • 7.3 Contact Us 72
  • 7.4 Disclaimer 72

List of Tables

1.1 List of Tables

  • Table 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 7
  • Table 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory 8
  • Table 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path 9
  • Table 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date 10
  • Table 5: Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development 11
  • Table 6: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 12
  • Table 7: Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 13
  • Table 8: CerePET - Product Status 13
  • Table 9: CerePET - Product Description 13
  • Table 10: FREEMotion - Product Status 14
  • Table 11: FREEMotion - Product Description 14
  • Table 12: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 13: Q.Clear - Product Status 15
  • Table 14: Q.Clear - Product Description 15
  • Table 15: General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 16: CareMiBrain - Product Status 16
  • Table 17: CareMiBrain - Product Description 16
  • Table 18: Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 19: Positron Emission Tomography System - Product Status 17
  • Table 20: Positron Emission Tomography System - Product Description 17
  • Table 21: Lightpoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 22: HARLI - Product Status 18
  • Table 23: HARLI - Product Description 18
  • Table 24: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 25: Additional PET Scan - Product Status 19
  • Table 26: Additional PET Scan - Product Description 19
  • Table 27: Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 28: Helmet - PET System - Product Status 20
  • Table 29: Helmet - PET System - Product Description 20
  • Table 30: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 31: Breast-Dedicated PET System - Product Status 21
  • Table 32: Breast-Dedicated PET System - Product Description 21
  • Table 33: Dual Panel PET Scanner - Product Status 22
  • Table 34: Dual Panel PET Scanner - Product Description 22
  • Table 35: Dual-isotope Positron Emitting Tomography System - Product Status 22
  • Table 36: Dual-isotope Positron Emitting Tomography System - Product Description 22
  • Table 37: MR Compatible PET System - Product Status 23
  • Table 38: MR Compatible PET System - Product Description 23
  • Table 39: Next Generation TOF-PET System - Product Status 23
  • Table 40: Next Generation TOF-PET System - Product Description 24
  • Table 41: PET Sensitivity Enhancing Device - Product Status 24
  • Table 42: PET Sensitivity Enhancing Device - Product Description 24
  • Table 43: PET System - Product Status 24
  • Table 44: PET System - Product Description 25
  • Table 45: SynchroPET Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 46: Breast PET-MRI - Product Status 26
  • Table 47: Breast PET-MRI - Product Description 26
  • Table 48: Wrist Scanner - Product Status 26
  • Table 49: Wrist Scanner - Product Description 27
  • Table 50: University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 51: PET Imaging Tool - Product Status 28
  • Table 52: PET Imaging Tool - Product Description 28
  • Table 53: University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 54: EXPLORER - Product Status 29
  • Table 55: EXPLORER - Product Description 29
  • Table 56: University of Washington Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 57: DS-PS3 Positron Emission Tomography Detector - Product Status 30
  • Table 58: DS-PS3 Positron Emission Tomography Detector - Product Description 30
  • Table 59: High Resolution PET Detector - Product Status 31
  • Table 60: High Resolution PET Detector - Product Description 31
  • Table 61: PET-Mammogram-Biopsy System - Product Status 31
  • Table 62: PET-Mammogram-Biopsy System - Product Description 32
  • Table 63: West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 64: Positron Emission Tomography (PET) Imager - Product Status 33
  • Table 65: Positron Emission Tomography (PET) Imager - Product Description 33
  • Table 66: Glossary 71

List of Figures

1.2 List of Figures

  • Figure 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 7
  • Figure 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory 8
  • Figure 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path 9
  • Figure 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date 10
Back to Top